Myriad Genetics Inc (NASDAQ:MYGN)

19.24
Delayed Data
As of Dec 01
 +0.15 / +0.79%
Today’s Change
13.82
Today|||52-Week Range
24.21
+32.60%
Year-to-Date

Today’s Trading

Previous close19.09
Today’s open18.72
Day’s range18.66 - 19.27
Volume16,294
Average volume (3 months)589,986
Market cap$1.7B
Data as of 3:59pm ET, 12/01/2023

Growth & Valuation

Earnings growth (last year)-298.51%
Earnings growth (this year)-7.78%
Earnings growth (next 5 years)-68.57%
Revenue growth (last year)-1.77%
P/E ratioNM
Price/Sales1.72
Price/Book1.76

Competitors

 Today’s
change
Today’s
% change
CLDXCelldex Therapeutics...+1.83+6.06%
----
----
VCYTVeracyte Inc+0.93+3.63%
Data as of 3:59pm ET, 12/01/2023

Financials

Next reporting dateFebruary 28, 2024
EPS forecast (this quarter)$0.04
Annual revenue (last year)$678.4M
Annual profit (last year)-$112.0M
Net profit margin-16.51%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Salt Lake City, Utah

Forecasts